Eli Lilly, the maker of blockbuster weight loss and diabetes drugs Zepbound and Mounjaro, said it will invest an additional ...
Coverage complications are not unusual in the U.S. health care system. But the challenge is magnified for these obesity ...
A study suggests that weight loss medications like Ozempic may help ... Eli Lilly says a new trial showed the key ingredient in its popular drugs Zepbound and Mounjaro helped slash the chance ...
Ongoing trials of the next generation of weight loss drugs are revealing something unexpected: Some patients are losing too ...
Eli Lilly has unveiled a $27bn investment in US manufacturing facilities as the pharmaceutical industry prepares for the threat of tariffs and mounts a charm offensive aimed at President Donald ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback